Daptomycin pharmacokinetics in critically ill patients receiving continuous venovenous hemodialysis.
about
The pharmacokinetics of oseltamivir and oseltamivir carboxylate in a critically ill pediatric patient receiving extracorporeal membrane oxygenation and continuous venovenous hemodialysisDaptomycin for a complicated urinary tract infection with vancomycin-resistant Enterococcus faecium in a renal transplant recipientA current perspective on daptomycin for the clinical microbiologist.Population pharmacokinetics of daptomycin in adult patients undergoing continuous renal replacement therapy.Pharmacokinetics of ertapenem in critically ill patients receiving continuous venovenous hemodialysis or hemodiafiltration.Antibiotic dosing in critically ill patients with acute kidney injury.Use of an in vitro model of renal replacement therapy systems to estimate extracorporeal drug removal.Current use of daptomycin in cardiac surgery and postoperative intensive care.Daptomycin dosing strategies in patients receiving thrice-weekly intermittent hemodialysis.Optimal dosing of antibiotics in critically ill patients by using continuous/extended infusions: a systematic review and meta-analysis.Antibiotic Dosing in Patients With Acute Kidney Injury: "Enough But Not Too Much".Antimicrobial dosing in critically ill patients with sepsis-induced acute kidney injuryTherapeutic drug monitoring of anti-infective agents in critically ill patients.Daptomycin Pharmacokinetics and Pharmacodynamics in Septic and Critically Ill Patients.Dosing strategies to optimize currently available anti-MRSA treatment options (Part 1: IV options).[Antibiotic dosing for renal function disorders and continuous renal replacement therapy].Daptomycin serum levels in critical patients undergoing continuous renal replacement.Experience with daptomycin daily dosing in ICU patients undergoing continuous renal replacement therapy.Pharmacokinetics of daily daptomycin in critically ill patients undergoing continuous renal replacement therapy.Monte Carlo simulation analysis of ceftobiprole, dalbavancin, daptomycin, tigecycline, linezolid and vancomycin pharmacodynamics against intensive care unit-isolated methicillin-resistant Staphylococcus aureus.Antibiotic dosing in critically ill patients receiving CRRT: underdosing is overprevalent.Pharmacokinetics of oseltamivir and oseltamivir carboxylate in critically ill patients receiving continuous venovenous hemodialysis and/or extracorporeal membrane oxygenation.
P2860
Q30423131-653E934C-F9AD-4535-A99C-7173253ABEA7Q35366674-8A98BD66-1E48-4E88-8A3F-242B34377BE3Q37263289-2B5C7908-9D60-4002-B701-9BE8C95F0C26Q37639909-2038F9F0-7D15-44DE-980A-FD22BF8D1912Q37643628-EFDBD9E7-C4E7-493E-A90A-FC87E71F5876Q37846092-2129936F-CE64-4A5F-B2E0-9E16FA541312Q37974648-BC22D6DD-84FA-4136-845C-BDC56FE2740FQ38086339-559B483C-9D84-4B0F-BE7F-DD83D409353CQ38164685-78A9BD30-AF8F-47D6-AD30-1CD93DD4E3F1Q38167345-AED2EB99-17C9-476C-9917-A5D672C4282FQ38261172-9EA68074-CA8C-467B-B930-40D5DCE5E60BQ38365787-3B93DC17-DA04-4DA4-A977-2092B0B8B986Q38790740-15FD057D-10CD-4D2D-A5A6-8E8E961E0163Q38895642-C5DF1EA2-02FD-4E84-8786-31335D4E417CQ38907793-1ACAE8BA-4421-45BE-9E47-D6DF31A15BD8Q41379961-D950B2F1-0CBC-4647-9B2E-9B58116D1421Q42285206-140D69EF-461F-4758-8591-0B8C39ECD09AQ43423980-EE1E3778-BE36-4E75-A80C-19D22887B084Q44235973-EB30C1B0-72BE-47F9-8BFD-81B41CA6CCB8Q46255695-A07CD364-8B0A-47C0-905C-9A6799604C9FQ51040518-6D07A373-D6A5-4F9F-8CD0-EFE103ED0DFCQ53351375-AE4920AE-8AC1-4C64-85C4-F1CF8A6ED0D2
P2860
Daptomycin pharmacokinetics in critically ill patients receiving continuous venovenous hemodialysis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Daptomycin pharmacokinetics in ...... nuous venovenous hemodialysis.
@en
type
label
Daptomycin pharmacokinetics in ...... nuous venovenous hemodialysis.
@en
prefLabel
Daptomycin pharmacokinetics in ...... nuous venovenous hemodialysis.
@en
P2093
P1476
Daptomycin pharmacokinetics in ...... nuous venovenous hemodialysis.
@en
P2093
A Mary Vilay
Daryl D Depestel
Kevin M Sowinski
Lihong Gao
Maricor Grio
Michael Heung
Noha N Salama
P356
10.1097/CCM.0B013E3181FA36FB
P407
P577
2011-01-01T00:00:00Z